Dataset Information

RF-GANs: A Method to Synthesize Retinal Fundus Images Based on Generative Adversarial Network.

ABSTRACT: Diabetic retinopathy (DR) is a diabetic complication affecting the eyes, which is the main cause of blindness in young and middle-aged people. In order to speed up the diagnosis of DR, a mass of deep learning methods have been used for the detection of this disease, but they failed to attain excellent results due to unbalanced training data, i.e., the lack of DR fundus images. To address the problem of data imbalance, this paper proposes a method dubbed retinal fundus images generative adversarial networks (RF-GANs), which is based on generative adversarial network, to synthesize retinal fundus images. RF-GANs is composed of two generation models, RF-GAN1 and RF-GAN2. Firstly, RF-GAN1 is employed to translate retinal fundus images from source domain (the domain of semantic segmentation datasets) to target domain (the domain of EyePACS dataset connected to Kaggle (EyePACS)). Then, we train the semantic segmentation models with the translated images, and employ the trained models to extract the structural and lesion masks (hereafter, we refer to it as Masks) of EyePACS. Finally, we employ RF-GAN2 to synthesize retinal fundus images using the Masks and DR grading labels. This paper verifies the effectiveness of the method: RF-GAN1 can narrow down the domain gap between different datasets to improve the performance of the segmentation models. RF-GAN2 can synthesize realistic retinal fundus images. Adopting the synthesized images for data augmentation, the accuracy and quadratic weighted kappa of the state-of-the-art DR grading model on the testing set of EyePACS increase by 1.53% and 1.70%, respectively.

SUBMITTER: Chen Y

PROVIDER: S-EPMC8598326 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:PurposeIn vivo confocal microscopy (IVCM) is a noninvasive, reproducible, and inexpensive diagnostic tool for corneal diseases. However, widespread and effortless image acquisition in IVCM creates serious image analysis workloads on ophthalmologists, and neural networks could solve this problem quickly. We have produced a novel deep learning algorithm based on generative adversarial networks (GANs), and we compare its accuracy for automatic segmentation of subbasal nerves in IVCM images with a fully convolutional neural network (U-Net) based method.MethodsWe have collected IVCM images from 85 subjects. U-Net and GAN-based image segmentation methods were trained and tested under the supervision of three clinicians for the segmentation of corneal subbasal nerves. Nerve segmentation results for GAN and U-Net-based methods were compared with the clinicians by using Pearson's R correlation, Bland-Altman analysis, and receiver operating characteristics (ROC) statistics. Additionally, different noises were applied on IVCM images to evaluate the performances of the algorithms with noises of biomedical imaging.ResultsThe GAN-based algorithm demonstrated similar correlation and Bland-Altman analysis results with U-Net. The GAN-based method showed significantly higher accuracy compared to U-Net in ROC curves. Additionally, the performance of the U-Net deteriorated significantly with different noises, especially in speckle noise, compared to GAN.ConclusionsThis study is the first application of GAN-based algorithms on IVCM images. The GAN-based algorithms demonstrated higher accuracy than U-Net for automatic corneal nerve segmentation in IVCM images, in patient-acquired images and noise applied images. This GAN-based segmentation method can be used as a facilitating diagnostic tool in ophthalmology clinics.Translational relevanceGenerative adversarial networks are emerging deep learning models for medical image processing, which could be important clinical tools for rapid segmentation and analysis of corneal subbasal nerves in IVCM images.

Project description:Drug design is an important area of study for pharmaceutical businesses. However, low efficacy, off-target delivery, time consumption, and high cost are challenges and can create barriers that impact this process. Deep Learning models are emerging as a promising solution to perform de novo drug design, i.e., to generate drug-like molecules tailored to specific needs. However, stereochemistry was not explicitly considered in the generated molecules, which is inevitable in targeted-oriented molecules. This paper proposes a framework based on Feedback Generative Adversarial Network (GAN) that includes optimization strategy by incorporating Encoder-Decoder, GAN, and Predictor deep models interconnected with a feedback loop. The Encoder-Decoder converts the string notations of molecules into latent space vectors, effectively creating a new type of molecular representation. At the same time, the GAN can learn and replicate the training data distribution and, therefore, generate new compounds. The feedback loop is designed to incorporate and evaluate the generated molecules according to the multiobjective desired property at every epoch of training to ensure a steady shift of the generated distribution towards the space of the targeted properties. Moreover, to develop a more precise set of molecules, we also incorporate a multiobjective optimization selection technique based on a non-dominated sorting genetic algorithm. The results demonstrate that the proposed framework can generate realistic, novel molecules that span the chemical space. The proposed Encoder-Decoder model correctly reconstructs 99% of the datasets, including stereochemical information. The model's ability to find uncharted regions of the chemical space was successfully shown by optimizing the unbiased GAN to generate molecules with a high binding affinity to the Kappa Opioid and Adenosine [Formula: see text] receptor. Furthermore, the generated compounds exhibit high internal and external diversity levels 0.88 and 0.94, respectively, and uniqueness.

Dataset Information

RF-GANs: A Method to Synthesize Retinal Fundus Images Based on Generative Adversarial Network.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets